1. Procedure complications 2. Complications due to the steroid use
Conditions
Interventions
1. Patients will be admitted to Chiang Mai University Hospital as one day surgery.
2. The spinal needle will be placed along the previous surgical scar or the expected future resection line of recurre
The tumor is progressive following the definition of “Progressed disease”
-
Local complications which determined as major complications
Experimental Drug
Sponsors
Faculty of medicine, Chiang mai University
Faculty of medicine,
Chiang mai University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients who have been diagnosed AF by MSK-Oncology Board (MSK-OB) of Chiang Mai University and give consent to participate in this research, and 2. The disease has recurred at least one episode and progressed after the wide resection had been performed, and - Patients have experience of constant pain and not response to conservative treatment, or - The primary lesion shows locally aggressive by involving large area of normal tissue (comparing to previous MRI), and the operation is expected to create unacceptable morbidity.
Exclusion criteria
Exclusion criteria: 1. Patients who have bleeding tendency 2. Patients who depended on systemic steroid use by other conditions 3. Patients who have contra-indication for steroid use including poor control diabetes, active infection, pregnancy and lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety for intratumoral steroid injection 6 months local of intratumoral injection and systemic and local steroid complications | — |
Secondary
| Measure | Time frame |
|---|---|
| outcome of treatment 6 months pain score, functional score and tumor volume | — |
Countries
Thailand
Contacts
Public Contactdumnoensun pruksakorn
Chiang Mai University
Outcome results
None listed